Target type: biologicalprocess
The process in which a cell becomes capable of differentiating autonomously into a neuron regardless of its environment; upon determination, the cell fate cannot be reversed. [GOC:dph]
Neuron fate determination is a complex and tightly regulated process that ensures the development of functional neurons from progenitor cells. It involves a series of intricate molecular events, including the activation of specific transcription factors, signaling pathways, and epigenetic modifications, that ultimately drive the acquisition of neuronal identity.
During early development, neural progenitor cells reside in specialized regions of the developing nervous system. These progenitors possess the potential to differentiate into various neural cell types, including neurons, astrocytes, and oligodendrocytes. The fate decision of a progenitor cell towards the neuronal lineage is initiated by a combination of intrinsic and extrinsic cues.
Intrinsic factors include the expression of specific transcription factors that play a crucial role in determining neuronal identity. These factors, such as Neurogenin (Neurog) and Mash1, act as master regulators of neuronal differentiation. Their activation leads to the upregulation of genes involved in neuronal function and morphology.
Extrinsic cues, such as growth factors and secreted signaling molecules, also influence neuronal fate determination. For example, the Wnt signaling pathway plays a critical role in promoting neuronal differentiation by regulating the expression of key transcription factors.
The process of neuronal fate determination is not a simple switch but involves a gradual transition from a progenitor state to a mature neuronal state. During this transition, progenitors undergo a series of morphological and functional changes. They extend neurites, form synapses, and acquire the ability to communicate with other neurons.
Epigenetic modifications, such as DNA methylation and histone acetylation, also contribute to neuronal fate determination by regulating gene expression. These modifications influence the accessibility of DNA to transcription factors, thereby controlling the activation of genes involved in neuronal development.
The precise mechanisms underlying neuronal fate determination are still under investigation. However, it is clear that a complex interplay of intrinsic and extrinsic factors, as well as epigenetic modifications, orchestrates the development of functional neurons. Understanding these mechanisms is crucial for developing therapeutic strategies for neurodevelopmental disorders and for promoting neuronal regeneration in the injured nervous system.'
"
Protein | Definition | Taxonomy |
---|---|---|
Cell division control protein 42 homolog | A cell division control protein 42 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P60953] | Homo sapiens (human) |
Catenin beta-1 | A catenin beta-1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P35222] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
fasudil | fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia. fasudil: intracellular calcium antagonist; structure in first source | isoquinolines; N-sulfonyldiazepane | antihypertensive agent; calcium channel blocker; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; geroprotector; neuroprotective agent; nootropic agent; vasodilator agent |
ketorolac | 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid : A member of the class of pyrrolizines that is 2,3-dihydro-1H-pyrrolizine which is substituted at positions 1 and 5 by carboxy and benzoyl groups, respectively. ketorolac : A racemate comprising equimolar amounts of (R)-(+)- and (S)-(-)-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid. While only the (S)-(-) enantiomer is a COX1 and COX2 inhibitor, the (R)-(+) enantiomer exhibits potent analgesic activity. A non-steroidal anti-inflammatory drug, ketorolac is mainly used (generally as the tromethamine salt) for its potent analgesic properties in the short-term management of post-operative pain, and in eye drops to relieve the ocular itching associated with seasonal allergic conjunctivitis. It was withdrawn from the market in many countries in 1993 following association with haemorrhage and renal failure. Ketorolac: A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is an NSAID and is used principally for its analgesic activity. (From Martindale The Extra Pharmacopoeia, 31st ed) | amino acid; aromatic ketone; monocarboxylic acid; pyrrolizines; racemate | analgesic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug |
salvin | salvin: a biocyclic diterpenoid; from sage and rosemary (Lamiaceae) | abietane diterpenoid; carbotricyclic compound; catechols; monocarboxylic acid | angiogenesis modulating agent; anti-inflammatory agent; antineoplastic agent; antioxidant; apoptosis inducer; food preservative; HIV protease inhibitor; plant metabolite |
toxoflavin | toxoflavin : A pyrimidotriazine that is 1,6-dimethyl-1,5,6,7-tetrahydropyrimido[5,4-e][1,2,4]triazine with oxo groups at positions 5 and 7. toxoflavin: azapteridine antibiotic; structure | carbonyl compound; pyrimidotriazine | antibacterial agent; antineoplastic agent; apoptosis inducer; bacterial metabolite; toxin; virulence factor; Wnt signalling inhibitor |
sanguinarine chloride | |||
chelerythrine chloride | |||
cercosporin | cercosporin : An organic heterohexacyclic compound that is perylo[1,12-def][1,3]dioxepine-6,11-dione substituted by hydroxy groups at positions 5 and 12, by methoxy groups at positions 7 and 10, and by 2-hydroxypropyl groups at positions 8 and 9 (the R,R-stereoisomer). It is a phytotoxin which was first isolated from the pathogenic soybean fungus, Cercospora kikuchii and later found in multiple members of the genus Cercospora. cercosporin: phyytotoxin from Cercospora beticola Sacc; posses photodynamic action on mice, bacteria & plants | ||
LSM-42773 | aromatic ketone | ||
etodolac, (-)-isomer | (R)-etodolac : The R-enantiomer of etodolac. It is inactive, in contrast to the enantiomer, (S)-etodolac, which is a preferential inhibitor of cyclo-oxygenase 2 and a non-steroidal anti-inflammatory. The racemate is commonly used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. | etodolac | |
2-[[benzamido(sulfanylidene)methyl]amino]-5,5-dimethyl-4,7-dihydrothieno[2,3-c]pyran-3-carboxylic acid | CID1067700: a pan-GTPase inhibitor; structure in first source | thienopyran | |
y 27632, dihydrochloride, (4(r)-trans)-isomer | |||
secramine a | secramine A: inhibits VSVG transport from the Golgi to the plasma membrane; also inhibits Cdc42-dependent cell functions; structure in first source | ||
ucn 1028 c | calphostin C: structure given in first source; isolated from Cladosporium cladosporioides |